Skip to content
Announcement:

Latest Publication: Read our teams’ latest paper in Antibiotics, showing reduced nephrotoxicity of a novel formulation of polymyxin B compared to the clinical formulation using a validated primary human proximal tubule cell model.

Covid-19 action plan – 2021 update

Covid 19 Update Banner

In line with our previous Covid-19 Action Plan, Newcells Biotech has continued to review and invest in measures to reduce the risk to its staff and our wider community from the Covid-19 virus.

We have reviewed our policies and procedures in light of the recent Government restrictions and implemented further measures including improved physical barriers, biosecurity procedures and work patterns to enable us to continue servicing our customers while maintaining the safety of our staff.

We wish all of our customers, suppliers and partners a safe and healthy 2021.

Dr Mike Nicholds
CEO
Newcells Biotech

Don't miss out on our latest innovations: follow us on Linkedin

Published

13th January, 2021

Categories

Update

Get our latest updates straight to your inbox